Significance of cerebral microinfarcts in antiphospholipid syndrome: A population-based study

被引:2
作者
Naftali, Jonathan [1 ,2 ]
Barnea, Rani [1 ,2 ]
Eliahou, Ruth [2 ,3 ]
Saliba, Walid [4 ,5 ]
Bloch, Sivan [5 ,6 ]
Findler, Michael [1 ,2 ]
Brauner, Ran [1 ,2 ]
Shochat, Tzippy [7 ]
Leader, Avi [8 ]
Auriel, Eitan [1 ,2 ]
机构
[1] Rabin Med Ctr, Dept Neurol, Zeev Jabotinsky St 39, Petah Tiqwa 49100, Israel
[2] Tel Aviv Univ, Fac Med, Tel Aviv, Israel
[3] Rabin Med Ctr, Dept Radiol, Petah Tiqwa, Israel
[4] Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel
[5] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel
[6] Lady Davis Carmel Med Ctr, Dept Neurol, Haifa, Israel
[7] Rabin Med Ctr, Petah Tiqwa, Israel
[8] Mem Sloan Kettering Canc Ctr, Dept Med, Hematol Serv, New York, NY USA
关键词
Acute ischemic stroke; antiphospholipid syndrome; MRI; DWI lesions; cerebral microinfarcts; lesions; ANTIBODIES; BIOMARKERS;
D O I
10.1177/17474930241293236
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Acute ischemic stroke (AIS) or transient ischemic attack (TIA) is the most common neurological manifestations of patients with antiphospholipid syndrome (APS). Incidental diffusion-weighted imaging (DWI) positive subcortical and cortical lesions, or acute incidental cerebral microinfarcts (CMI), are microscopic ischemic lesions, detectable on MRI for 10-14 days only. We aimed to look at the prevalence of acute incidental CMI in a cohort of patients with APS and their association with subsequent AIS or TIA. Methods: This is a population-based cohort study of adults with APS diagnosis using International Statistical Classification-9 (ICD-9) and supporting laboratory results between January 2014 and April 2020. We included any patient undergoing brain MRI (index event) during the year prior APS diagnosis or at any time point following diagnosis. Age-matched subjects with negative APS laboratory workup were used as a control group. In the first analysis, we compared acute incidental CMI prevalence in both groups. We then performed a second analysis among APS patients only, comparing patients with and without acute incidental CMI for AIS or TIA as the primary outcome. Cox proportional hazards models used to calculate hazards ratio (HR) and 4 years cumulative risk. Results: 292 patients were included, of which, 207 patients with APS. Thirteen patients with APS had acute incidental CMI on MRI (6.3%), compared with none in the control group (p = 0.013). Following multivariable analysis, APS was the sole factor associated with acute incidental CMI (p = 0.026). During a median follow-up of 4 years (IQR 3.5, 4) in patients with APS, following multivariable analysis, acute incidental CMI was associated with subsequent AIS or TIA (HR 6.73 [(95% CI, 1.96-23.11], p < 0.01). Conclusion: Acute incidental CMI are more common among patients with APS than in patients with negative APS tests, and are associated with subsequent AIS or TIA. Detecting acute incidental CMI in patients with APS may guide etiological workup and reevaluation of antithrombotic regimen.
引用
收藏
页码:186 / 195
页数:10
相关论文
共 50 条
  • [31] Clinical and immunological characteristics of antiphospholipid syndrome in an Asian population: a retrospective study
    Jatuworapruk, Kanon
    Bhoopat, Lantarima
    Hanvivadhanakul, Punchong
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2019, 37 (03) : 171 - 178
  • [32] Lipid-binding antiphospholipid antibodies: significance for pathophysiology and diagnosis of the antiphospholipid syndrome
    Mueller-Calleja, Nadine
    Ruf, Wolfram
    Lackner, Karl J.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2024, 61 (05) : 370 - 387
  • [33] Longitudinal assessment of cerebral infarcts and small vessel disease using magnetic resonance imaging in antiphospholipid syndrome: A single-centre retrospective study
    Tan, Yishi
    Doyle, Andrew J.
    Kumar, Jayant
    Somerville, Peter
    Faruqi, Uzma
    Danaee, Anicee
    Luo, Pu-Lin
    Hunt, Beverley J.
    Breen, Karen A.
    EJHAEM, 2025, 6 (01):
  • [34] The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome
    Diz-Kucukkaya, Reyhan
    Hancer, Veysel Sabri
    Artim-Esen, Bahar
    Pekcelen, Yuksel
    Inanc, Murat
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 29 (03) : 303 - 309
  • [35] Clinical characteristics and outcomes of cerebral venous sinus thrombosis in patients with antiphospholipid syndrome
    Xu, Zhejun
    Huang, Can
    Jiang, Hui
    Zhao, Yuan
    Zhou, Yangzhong
    Hu, Chaojun
    Han, Fei
    Yao, Ming
    Ni, Jun
    Li, Mengtao
    Zeng, Xiaofeng
    Zhou, Lixin
    Zhao, Jiuliang
    CLINICAL RHEUMATOLOGY, 2024, 43 (12) : 3747 - 3757
  • [36] Development of cerebral venous sinus thrombosis in an aplastic anemia patient with antiphospholipid syndrome
    Chen Jian-hua
    You Xin
    Qian Min
    CHINESE MEDICAL JOURNAL, 2010, 123 (17) : 2486 - 2488
  • [37] Histopathological analysis of cerebral hemorrhage in systemic lupus erythematosus complicated with antiphospholipid syndrome
    Arinuma, Yoshiyuki
    Kikuchi, Hirotoshi
    Aramaki, Kaori
    Kyogoku, Masahisa
    Hirohata, Shunsei
    MODERN RHEUMATOLOGY, 2011, 21 (05) : 509 - 513
  • [38] Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study
    Ricard, Laure
    Laurent, Charlotte
    Papo, Matthias
    Deriaz, Sophie
    Catano, Jennifer
    Alamowitch, Sonia
    Kayem, Gilles
    Chasset, Francois
    De Moreuil, Claire
    Boffa, Jean Jacques
    Gerotziafas, Grigorios
    Elalamy, Ismail
    Bornes, Marie
    Maillot, Francois
    Audemard-Verger, Alexandra
    Planche, Virginie
    Ballot, Eric
    Fain, Olivier
    Mekinian, Arsene
    JOINT BONE SPINE, 2022, 89 (02)
  • [39] The clinical significance of the seronegative antiphospholipid syndrome in pregnancy morbidity
    Berceanu, C.
    Vladareanu, S.
    Cirstoiu, M. M.
    Mehedintu, C.
    Comandasu, D.
    Berceanu, S.
    Bratila, E.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 : 8 - 8
  • [40] Calcified Neurocysticercosis Associates with Hippocampal Atrophy: A Population-Based Study
    Del Brutto, Oscar H.
    Salgado, Perla
    Lama, Julio
    Del Brutto, Victor J.
    Campos, Xavier
    Zambrano, Mauricio
    Garcia, Hector H.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 92 (01) : 64 - 68